You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR STRENSIQ

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for STRENSIQ

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02797821 ↗	Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)	Completed	Alexion Pharmaceuticals	Phase 2	2016-06-06	The purpose of this study was to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of asfotase alfa in adult participants with pediatric-onset HPP.
NCT06015750 ↗	Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia	Not yet recruiting	Alexion Pharmaceuticals, Inc.	Phase 4	2024-04-30	The primary objective of this study is to evaluate the effect of immunosuppressive therapy (IST) in participants treated with asfotase alfa who demonstrate immune-mediated loss of effectiveness (LoE).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for STRENSIQ

Condition Name

Chart
Table

Condition Name for STRENSIQ
Intervention	Trials
Hypophosphatasia	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for STRENSIQ
Intervention	Trials
Hypophosphatasia	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for STRENSIQ

Trials by Country

Map
Table

Trials by Country for STRENSIQ
Location	Trials
United States	3
Germany	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for STRENSIQ
Location	Trials
Tennessee	1
North Carolina	1
Missouri	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for STRENSIQ

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for STRENSIQ
Clinical Trial Phase	Trials
Phase 4	1
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for STRENSIQ
Clinical Trial Phase	Trials
Not yet recruiting	1
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for STRENSIQ

Sponsor Name

Chart
Table

Sponsor Name for STRENSIQ
Sponsor	Trials
Alexion Pharmaceuticals	1
Alexion Pharmaceuticals, Inc.	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for STRENSIQ
Sponsor	Trials
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.